Skip to search formSkip to main contentSkip to account menu

16 ML bevacizumab 25 MG/ML Injection [Avastin]

Known as: Avastin 400 MG in 16 ML Injection, Avastin 400 MG per 16 ML Injection, bevacizumab 400 mg in 16 mL INTRAVENOUS INJECTION, SOLUTION [Avastin] 
National Institutes of Health

Related topics

Related topics

7 relations
AvastinInjectionPolysorbate 20SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Avastin®/Lucentis® : Lettre ouverte du SMG à François Hollande
Nous publions ici in extenso et sans commentaires la lettre adressee par le SMG au President de la Republique. 
Highly Cited
2015
Highly Cited
2015
An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
2014
2014
[Avastin-Lucentis: off-label and surroundings].
In Italy, the debate on the off-label use of intravitreal bevacizumab in patients with age-related macular degeneration (AMD) has… 
2012
2012
Proteins from Avastin® (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear
Avastin® (bevacizumab) is a protein drug widely used for cancer treatment although its further use is questionable due to serious… 
2011
2011
Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia…
BACKGROUND Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia and severe, recurrent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)